Equinix Inc (EQIX):企業の財務・戦略的SWOT分析

◆英語タイトル:Equinix Inc (EQIX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDTC29141FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Technology and Communications
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Equinix Inc (EQIX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Equinix Inc (Equinix) provides datacenters and co-location, interconnection and connectivity, data hub and marketplace, and professional services. The company provides applications and cloud infrastructure, wan optimization, and disaster recovery and business continuity solutions. Equinix also offers secure key management, marketplace, consulting, customer support and managed services. It serves healthcare, cloud services, payments, automotive, IoT, federal government, network service providers, managed service providers, and content and digital media. Equinix markets solutions through direct sales force and channel marketing programs. The company operates international business exchange (IBX) data centers in Atlanta, Boston, Dallas, Chicago, Denver, Miami, Los Angeles, Philadelphia, New York, Silicon Valley, Seattle and Washington D.C. Equinix is headquartered in Redwood City, California, the US.

Equinix Inc Key Recent Developments

Feb 10,2021: Equinix Reports Fourth Quarter And Full Year 2020 Results
Jan 14,2020: Itron expands collaboration with Equinix in EMEA to Strengthen Software-as-a-Service Platform

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Equinix Inc – Key Facts
Equinix Inc – Key Employees
Equinix Inc – Key Employee Biographies
Equinix Inc – Major Products and Services
Equinix Inc – History
Equinix Inc – Company Statement
Equinix Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Equinix Inc – Business Description
Business Segment: Co-location services
Overview
Performance
Business Segment: Interconnection Services
Overview
Performance
Business Segment: Managed Infrastructure
Overview
Performance
Business Segment: Others
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: EMEA
Performance
Equinix Inc – Corporate Strategy
Equinix Inc – SWOT Analysis
SWOT Analysis – Overview
Equinix Inc – Strengths
Equinix Inc – Weaknesses
Equinix Inc – Opportunities
Equinix Inc – Threats
Equinix Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Equinix Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 10, 2021: Equinix Reports Fourth Quarter And Full Year 2020 Results
Jan 14, 2020: Itron expands collaboration with Equinix in EMEA to Strengthen Software-as-a-Service Platform
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Equinix Inc, Key Facts
Equinix Inc, Key Employees
Equinix Inc, Key Employee Biographies
Equinix Inc, Major Products and Services
Equinix Inc, History
Equinix Inc, Other Locations
Equinix Inc, Subsidiaries
Equinix Inc, Key Competitors
Equinix Inc, Ratios based on current share price
Equinix Inc, Annual Ratios
Equinix Inc, Annual Ratios (Cont...1)
Equinix Inc, Annual Ratios (Cont...2)
Equinix Inc, Interim Ratios
Equinix Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Equinix Inc (EQIX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Entasis Therapeutics Inc (ETTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Entasis Therapeutics Inc (Entasis) is a drug development company that discovers and develops anti-infective therapies for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, ETX0282, ETX0914 and Zoliflodacin. Its ETX2514 is a potent inhibitor of class A, C, …
  • Enel Green Power SpA:企業の戦略的SWOT分析
    Enel Green Power SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Machavert Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Machavert Pharmaceuticals LLC (Machavert Pharmaceuticals) is a bio-pharmaceutical company which develops novel non-toxic medicines for the treatment of cancer and autoimmune diseases. Its lead drug candidate MP1000, a nanoparticulate liposomal phospholipid immune-modulating agent exhibits an …
  • Shanghai ChemPartner Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai ChemPartner Co Ltd (ChemPartner) is a life science contract research organization. The organization’s services include manufacturing of small molecules and biologics, drug discovery and development, biomarkers, preclinical and clinical sample bioanalysis, and analytical services, am …
  • Compugen Ltd.:企業のM&A・事業提携・投資動向
    Compugen Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Compugen Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Quanta Services Inc (PWR)-石油・ガス分野:企業M&A・提携分析
    Summary Quanta Services, Inc. (Quanta) is a specialized contracting services company that offers infrastructure solutions. It designs, installs, upgrades, repairs and maintains infrastructure of electric power transmission and distribution networks, substation facilities, renewable energy facilities …
  • GKE Corporation Limited (595):企業の財務・戦略的SWOT分析
    GKE Corporation Limited (595) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Anadarko Petroleum Corp (APC):企業の財務・戦略的SWOT分析
    Anadarko Petroleum Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Clinigen Group Plc (CLIN):企業の財務・戦略的SWOT分析
    Summary Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It off …
  • Neovasc Inc (NVCN):医療機器:M&Aディール及び事業提携情報
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • Canpotex Ltd:企業の戦略的SWOT分析
    Canpotex Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Westminster Travel Limited:企業の戦略・SWOT・財務分析
    Westminster Travel Limited - Strategy, SWOT and Corporate Finance Report Summary Westminster Travel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Quotient Sciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Quotient Sciences Ltd (Quotient Sciences), formerly Pharmaceutical Profiles Group Ltd is a drug development service provider. The company offers services such as formulation development, clinical trial manufacturing, clinical pharmacology, and commercial manufacturing services. Its formulati …
  • Hanmi Pharmaceuticals Co Ltd (128940)-製薬・医療分野:企業M&A・提携分析
    Summary Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counte …
  • Oil and Natural Gas Corporation Limited:企業の戦略・SWOT・財務分析
    Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Daimler AG (DAI):企業の財務・戦略的SWOT分析
    Daimler AG (DAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NanoString Technologies Inc (NSTG)-医療機器分野:企業M&A・提携分析
    Summary NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, ge …
  • Genworth Financial, Inc.:企業のM&A・事業提携・投資動向
    Genworth Financial, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genworth Financial, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Shell Pakistan Ltd (SHEL):企業の財務・戦略的SWOT分析
    Summary Shell Pakistan Ltd (Shell Pakistan), a subsidiary of Royal Dutch Shell plc is an oil and gas company that markets petroleum products and compressed natural gas. The company operates through three segments such as retail, lubricants and aviation. It retail segment offers a range of fuels such …
  • Astellas Pharma Inc (4503):製薬・医療:M&Aディール及び事業提携情報
    Summary Astellas Pharma Inc (Astellas) is a research based pharmaceutical company that discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The company’s product portfolio comprises both marketed products for the treatment of a wide range of urological diseases, inf …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆